Zenji, member c.
This is an open-label observational single-group clinical trial to study the efficacy of a commercially available dietary supplement and its effect on common PMS and menstrual symptoms. It is hypothesized that the dietary supplement marketed as "Elix Cycle Balance" will improve subjective wellbeing in trial participants by alleviating common symptoms of PMS and menstrual symptoms, such as cramps, bloating, and mood swings. A total of 65 participants will be recruited for the trial following screening, with the expectation that at least 50 participants will complete the trial. The trial will be fully remote, a technology platform will be utilized to screen, enroll and capture study data of the participants. The total intervention study period will be 3 months.
PMS
Menstrual Pain
Elix Cycle Balance
Not Applicable
Study Type : | Interventional |
Estimated Enrollment : | 65 participants |
Masking : | None (Open Label) |
Masking Description : | Open-label observational single-group |
Primary Purpose : | Other |
Official Title : | Study to Evaluate the Efficacy of Elix's Cycle Balance and Its Impact on PMS and Menstrual Symptoms |
Actual Study Start Date : | March 5, 2022 |
Estimated Primary Completion Date : | May 31, 2022 |
Estimated Study Completion Date : | May 31, 2022 |
Arm | Intervention/treatment |
---|---|
Other: Elix Cycle Balance Elix Cycle Balance supplement |
Dietary Supplement: Elix Cycle Balance |
Ages Eligible for Study: | 18 Years to 36 Years |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Accepts Healthy Volunteers |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Citruslabs
Santa Monica, California, United States, 90404